NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
about
Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.Cutaneous melanoma: From pathogenesis to therapy (Review).The Major Role of NF-kB in the Depth of Invasion on Acral Melanoma by Decreasing CD8+ T Cells.MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With Mutation Detected in Circulating-Free DNA
P2860
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
@en
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
@nl
type
label
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
@en
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
@nl
prefLabel
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
@en
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
@en
P2093
Claudio Guarneri
Grazia Malaponte
Massimo Libra
Patrizia S Cannavò
Valentina Bevelacqua
P2860
P304
P356
10.3892/OR.2017.5362
P577
2017-01-10T00:00:00Z